|
2023
|
Invention
|
Phosphoramidate-based psma-targeted small-molecule drug conjugates. The present invention relates... |
|
|
Invention
|
18f-labeled psma-targeted pet imaging agents.
Compounds of Marlush formula (I) described in the ... |
|
2021
|
Invention
|
Chelated psma inhibitors.
Provided herein are compounds of Formula (I) or a pharmaceutically acc... |
|
|
Invention
|
Methods of treating psma-positive cancer using radionuclide therapy.
The invention relates to me... |
|
|
Invention
|
Methods of treating psma-positive cancer using radionuclide therapy. The invention relates to met... |
|
2020
|
Invention
|
Chelate-containing psma inhibitors. Provided herein are PMSA-binding molecules comprising a album... |
|
2018
|
Invention
|
Chelated psma inhibitors. Compounds as defined herein are provided which are useful in (1) diagno... |
|
2017
|
Invention
|
Albumin-binding psma inhibitors. 2 are each independently a covalent bond or a divalent linking g... |
|
|
Invention
|
Albumin-binding psma inhibitors. Provided herein are compounds of Formula (I) or a pharmaceutical... |
|
|
Invention
|
Chelated psma inhibitors. Provided herein are compounds of Formula (I) or a pharmaceutically acce... |
|
2014
|
Invention
|
18f-labeled psma-targeted pet imaging agents. Compounds of Marlush formula (I) described in the c... |
|
2013
|
Invention
|
Psma inhibitors. Compounds as defined herein are provided which are useful in (1) diagnostic meth... |
|
|
Invention
|
Formulation of radiopharmaceuticals containing multiple acidic groups. The invention relates to t... |
|
2010
|
Invention
|
Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use. Compounds of th... |
|
2007
|
Invention
|
Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use. Compounds of the... |
